agilon health, inc. (NYSE:AGL) Director Purchases $28,500.00 in Stock

agilon health, inc. (NYSE:AGL) Director Diana Mckenzie bought 12,500 shares of the stock in a transaction on Monday, November 25th. The stock was purchased at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the purchase, the director now directly owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Diana Mckenzie also recently made the following trade(s):

• On Monday, December 9th, Diana Mckenzie purchased 7,500 shares of agilon health stock. The shares were purchased at an average price of $2.20 per share, with a total value of $16,500.00.

agilon health Stock Performance

Shares of AGL stock traded down $0.10 during mid-day trading on Wednesday, reaching $2.00. The stock had a trading volume of 3,318,747 shares, compared to its average volume of 4,867,141. The firm has a market cap of $821.98 million, a PE ratio of -2.23 and a beta of 0.51. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a one year low of $1.50 and a one year high of $13.76. The firm’s 50 day simple moving average is $2.51 and its 200 day simple moving average is $4.46.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same quarter in the prior year, the firm earned ($0.06) EPS. On average, analysts forecast that agilon health, inc. will post -0.5 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on AGL shares. William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. TD Cowen cut their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Royal Bank of Canada reiterated an “outperform” rating and set a $3.00 price target on shares of agilon health in a research note on Tuesday, November 19th. Finally, Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research note on Wednesday, October 2nd. Three research analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $5.02.

Hedge Funds Weigh In On agilon health

Hedge funds and other institutional investors have recently modified their holdings of the stock. AQR Capital Management LLC lifted its holdings in shares of agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after acquiring an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC lifted its holdings in agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after purchasing an additional 316,856 shares during the last quarter. Citigroup Inc. boosted its position in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after buying an additional 1,941,993 shares in the last quarter. Simplicity Wealth LLC boosted its position in agilon health by 145.1% in the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock valued at $171,000 after buying an additional 15,515 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new stake in agilon health during the second quarter worth about $1,849,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.